Immunotherapy to Target Both Long COVID & Fatigue Syndrome
Discover the immuno-pathophysiological similarities between long COVID and fatigue syndrome. Learn more about immunotherapy addressing both conditions.
Stay updated with breaking news from Professor Tate. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Discover the immuno-pathophysiological similarities between long COVID and fatigue syndrome. Learn more about immunotherapy addressing both conditions.
People suffering from Long COVID or Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) could benefit from a coordinated treatment strategy, a new University of Otago study has found
<p>People suffering from Long COVID or Myalgic Encephalomyelitis /Chronic Fatigue Syndrome (ME/CFS) could benefit from a coordinated treatment strategy, a new University of Otago study has found.</p> <p>The pilot study, published in <em>Scientific Reports</em>, a <em>Nature</em> journal, has confirmed what researchers have suspected for some time: the two conditions are closely related.</p> <p>Lead author Emeritus Professor Warren Tate says the research - the first comparative molecular study of the immune cell proteins of both conditions -...
People suffering from Long COVID or Myalgic Encephalomyelitis /Chronic Fatigue Syndrome (ME/CFS) could benefit from a coordinated treatment strategy, a new University of Otago study has found.